Cargando…
VASH2 Promotes Cell Proliferation and Resistance to Doxorubicin in Non-Small Cell Lung Cancer via AKT Signaling
Vasohibin2 (VASH2), a proangiogenic factor, has been demonstrated to play an oncogenic role in some common human cancers. However, the detailed function of VASH2 in non-small cell lung cancer (NSCLC) has not previously been studied. In this study, we found that VASH2 was significantly upregulated in...
Autores principales: | Tan, Xiangbin, Liao, Zefei, Zou, Shuangyou, Ma, Liangyun, Wang, Aimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851523/ https://www.ncbi.nlm.nih.gov/pubmed/30940294 http://dx.doi.org/10.3727/096504019X15509383469698 |
Ejemplares similares
-
VASH1–SVBP and VASH2–SVBP generate different detyrosination profiles on microtubules
por: Ramirez-Rios, Sacnicte, et al.
Publicado: (2022) -
MicroRNA-4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells
por: Zhang, Tao, et al.
Publicado: (2017) -
Structural basis of tubulin detyrosination by VASH2/SVBP heterodimer
por: Zhou, Chen, et al.
Publicado: (2019) -
Cryo-EM structure of VASH1-SVBP bound to microtubules
por: Li, Faxiang, et al.
Publicado: (2020) -
A preliminary study on the mechanism of VASH2 in childhood medulloblastoma
por: Liu, Wen, et al.
Publicado: (2023)